Semler Scientific (SMLR) Competitors

Tandem Diabetes Care (NASDAQ:TNDM) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, community ranking, earnings, risk and media sentiment.

Is TNDM or SMLR more profitable?

Semler Scientific has a net margin of 72.65% compared to Tandem Diabetes Care's net margin of -14.84%. Semler Scientific's return on equity of 50.77% beat Tandem Diabetes Care's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tandem Diabetes Care	-14.84%	-44.19%	-11.99%
Semler Scientific	72.65%	50.77%	47.04%

Which has more risk and volatility, TNDM or SMLR?

Tandem Diabetes Care has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in TNDM or SMLR?

49.4% of Semler Scientific shares are owned by institutional investors. 1.9% of Tandem Diabetes Care shares are owned by insiders. Comparatively, 30.2% of Semler Scientific shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community favor TNDM or SMLR?

Tandem Diabetes Care received 588 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 60.76% of users gave Tandem Diabetes Care an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote.

Company	Underperform	Outperform
Tandem Diabetes Care	Outperform Votes 590 60.76%	Underperform Votes 381 39.24%
Semler Scientific	Outperform Votes 2 50.00%	Underperform Votes 2 50.00%

Which has preferable valuation & earnings, TNDM or SMLR?

Semler Scientific has lower revenue, but higher earnings than Tandem Diabetes Care. Semler Scientific is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tandem Diabetes Care	$982.95M	1.46	-$222.61M	-$2.78	-7.75
Semler Scientific	$49.23M	7.18	$20.58M	-$2.61	-12.15

Does the media prefer TNDM or SMLR?

In the previous week, Semler Scientific had 8 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 15 mentions for Semler Scientific and 7 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.07 beat Semler Scientific's score of 0.12 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tandem Diabetes Care	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Semler Scientific	2 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Do analysts prefer TNDM or SMLR?

Tandem Diabetes Care currently has a consensus target price of $34.15, suggesting a potential upside of 58.49%. Semler Scientific has a consensus target price of $71.00, suggesting a potential upside of 123.90%. Given Semler Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Semler Scientific is more favorable than Tandem Diabetes Care.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tandem Diabetes Care	0 Sell rating(s)	8 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.43
Semler Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Semler Scientific beats Tandem Diabetes Care on 12 of the 18 factors compared between the two stocks.